The value of prospective monitoring of Epstein-Barr virus DNA in blood samples of pediatric liver transplant recipients

Transplant Infectious Disease

Volumn 6, Issue 1, 2004, Pages 15-22

  Scheenstra, R ^a   Verschuuren, E A M ^a   De Haan, A ^a   Slooff, M J H ^a   The, T H ^a   Bijleveld, C M A ^a   Verkade, H J ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Epstein Barr virus; Liver transplantation; Pediatric; Posttransplant lymphoproliferative disease (PTLD); Quantitative PCR

Indexed keywords

ACICLOVIR; CYCLOSPORIN; EPSTEIN BARR NUCLEAR ANTIGEN 1; EPSTEIN BARR VIRUS ANTIGEN; FOSCARNET; GANCICLOVIR; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; METHYLPREDNISOLONE; PREDNISOLONE; TACROLIMUS; UNCLASSIFIED DRUG; VIRUS CAPSID ANTIGEN; VIRUS DNA;

ADOLESCENT; ALAGILLE SYNDROME; ALPHA 1 ANTITRYPSIN DEFICIENCY; ARTICLE; AUTOIMMUNE HEPATITIS; BILE DUCT ATRESIA; BLOOD SAMPLING; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; EPSTEIN BARR VIRUS; HIGH RISK PATIENT; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFANT; INSULINOMA; LIVER FIBROSIS; LIVER METASTASIS; LIVER TRANSPLANTATION; LYMPHOPROLIFERATIVE DISEASE; MORBIDITY; MORTALITY; PATIENT MONITORING; PEDIATRIC SURGERY; POLYMERASE CHAIN REACTION; POSTTRANSPLANT LYMPHOPROLIFERATIVE DISEASE; PRIMARY SCLEROSING CHOLANGITIS; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK FACTOR; VIRUS INFECTION; VIRUS LOAD;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; DNA, VIRAL; EPSTEIN-BARR VIRUS INFECTIONS; HERPESVIRUS 4, HUMAN; HUMANS; INFANT; LIVER TRANSPLANTATION; LYMPHOPROLIFERATIVE DISORDERS; POLYMERASE CHAIN REACTION; PROSPECTIVE STUDIES; VIRAL LOAD;

EID: 3242740977     PISSN: 13982273     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-3062.2004.00044.x     Document Type: Article

References (24)

1. CRAIG FE, GULLEY ML, BANKS PM. Posttransplantation lymphoproliferative disorders. Am J Clin Pathol 1993: 99: 265-276.
2. BAUMFORTH KR, YOUNG LS, FLAVELL KJ, CONSTANDINOU C, MURRAY PG. The Epstein-Barr virus and its association with human cancers. Mol Pathol 1999: 52: 307-322.
3. SMETS F, SOKAL EM. Epstein-Barr virus-related lymphoproliferation in children after liver transplant: role of immunity, diagnosis, and management. Pediatr Transplant 2002: 6: 280-287.
4. PAYA CV, FUNG JJ, NALESNIK MA, et al. Epstein-Barr virus-induced posttransplant lymphoproliferative disorders. ASTS/ASTP EBV-PTLD Task Force and the Mayo Clinic Organized International Consensus Development Meeting. Transplantation 1999: 68: 1517-1525.
5. McDIARMID SV, JORDAN S, KIM GS, et al. Prevention and preemptive therapy of postransplant lymphoproliferative disease in pediatric liver recipients. Transplantation 1998: 66: 1604-1611.
6. ELLIS D, JAFFE R, GREEN M, et al. Epstein-Barr virus-related disorders in children undergoing renal transplantation with tacrolimus-based immunosuppression. Transplantation 1999: 68: 997-1003.
7. STEVENS SJ, VERSCHUUREN EA, PRONK I, et al. Frequent monitoring of Epstein-Barr virus DNA load in unfractionated whole blood is essential for early detection of posttransplant lymphoproliferative disease in high-risk patients. Blood 2001: 97: 1165-1171.
8. BALDANTI F, GROSSI P, FURIONE M, et al. High levels of Epstein-Barr virus DNA in blood of solid-organ transplant recipients and their value in predicting Posttransplant lymphoproliferative disorders. J Clin Microbiol 2000: 38: 613-619.
9. SAVOIE A, PERPETE C, CARPENTIER L, JONCAS J, ALFIERI C. Direct correlation between the load of Epstein-Barr virus-infected lymphocytes in the peripheral blood of pediatric transplant patients and risk of lymphoproliferative disease. Blood 1994: 83: 2715-2722.
10. ROWE DT, QU L, REYES J, et al. Use of quantitative competitive PCR to measure Epstein-Barr virus genome load in the peripheral blood of pediatric transplant patients with lymphoproliferative disorders. J Clin Microbiol 1997: 35: 1612-1615.
11. HENLE W, HENLE GE, HORWITZ CA. Epstein-Barr virus specific diagnostic tests in infectious mononucleosis. Hum Pathol 1974: 5: 551-565.
12. VAN DEN BERG AP, TEGZESS AM, SCHOLTEN-SAMPSON A, et al. Monitoring antigenemia is useful in guiding treatment of severe cytomegalovirus disease after organ transplantation. Transpl Int 1992: 5: 101-106.
13. STEVENS SJ, VERVOORT MB, VAN DEN BRULE AJ, MEENHORST PL, MEIJER CJ, MIDDELDORP JM. Monitoring of Epstein-Barr virus DNA load in peripheral blood by quantitative competitive PCR. J Clin Microbiol 1999: 37: 2852-2857.
14. BARLETTA JM, KINGMA DW, LING Y, CHARACHE P, MANN RB, AMBINDER RF. Rapid in situ hybridization for the diagnosis of latent Epstein-Barr virus infection. Mol Cell Probes 1993: 7: 105-109.
15. SMETS F, LATINNE D, BAZIN H, et al. Ratio between Epstein-Barr viral load and anti-Epstein-Barr virus specific T-cell response as a predictive marker of posttransplant lymphoproliferative disease. Transplantation 2002: 73: 1603-1610.
16. SMETS F, BODEUS M, GOUBAU P, et al. Characteristics of Epstein-Barr virus primary infection in pediatric liver transplant recipients. J Hepatol 2000: 32: 100-104.
17. SPADA M, GUIZZETTI M, PETZ W, et al. Circulating EBV-DNA in the monitoring of EBV infection in pediatric liver transplant recipients. Transplant Proc 2001: 33: 1835-1837.
18. WAGNER HJ, WESSEL M, JABS W, et al. Patients at risk for development of posttransplant lymphoproliferative disorder: plasma versus peripheral blood mononuclear cells as material for quantification of Epstein-Barr viral load by using real-time quantitative polymerase chain reaction. Transplantation 2001: 72: 1012-1019.
19. GREEN M, CACCIARELLI TV, MAZARIEGOS GV, et al. Serial measurement of Epstein-Barr viral load in peripheral blood in pediatric liver transplant recipients during treatment for posttransplant lymphoproliferative disease. Transplantation 1998: 66: 1641-1644.
20. ORII T, OHKOHCHI N, KIKUCHI H, et al. Usefulness of quantitative real-time polymerase chain reaction in following up patients with Epstein-Barr virus infection after liver transplantation. Clin Transplant 2000: 14: 308-317.
21. ORENTAS RJ, SCHAUER DW Jr, ELLIS FW, WALCZAK J, CASPER JT, MARGOLIS DA. Monitoring and modulation of Epstein-Barr virus loads in pediatric transplant patients. Pediatr Transplant 2003: 7: 305-314.
22. RANDHAWA P, BLAKOLMER K, KASHYAP R, et al. Allograft liver biopsy in patients with Epstein-Barr virus-associated posttransplant lymphoproliferative disease. Am J Surg Pathol 2001: 25: 324-330.
23. GREEN M, KAUFMANN M, WILSON J, REYES J. Comparison of intravenous ganciclovir followed by oral acyclovir with intravenous ganciclovir alone for prevention of cytomegalovirus and Epstein-Barr virus disease after liver transplantation in children. Clin Infect Dis 1997: 25: 1344-1349.
24. HOLMES RD, ORBAN-ELLER K, KARRER FR, ROWE DT, NARKEWICZ MR, SOKOL RJ. Response of elevated Epstein-Barr virus DNA levels to therapeutic changes in pediatric liver transplant patients: 56-month follow up and outcome. Transplantation 2002: 74: 367-372.